Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
5.01
-0.32 (-6.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Genenta Science Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -8.92 | -11.65 | -8.48 | -5.53 | -5.59 | -4.6 |
| Depreciation & Amortization | 0.04 | 0.04 | 0.01 | 0 | 0 | - |
| Stock-Based Compensation | 0.56 | 0.74 | 0.72 | 0.5 | 0.46 | 0.75 |
| Other Operating Activities | 0.06 | 0.08 | 0.09 | 0.01 | 0.01 | 0 |
| Change in Accounts Payable | 0.12 | -0.73 | 1 | -0.37 | -0.02 | -0.03 |
| Change in Other Net Operating Assets | 2.46 | 0.31 | -0.76 | -1.58 | -0.9 | 1.38 |
| Operating Cash Flow | -5.68 | -11.21 | -7.42 | -6.96 | -6.04 | -2.49 |
| Capital Expenditures | -0 | -0.01 | -0.03 | -0.01 | -0.02 | - |
| Investment in Securities | -0.59 | -14.88 | - | - | - | - |
| Investing Cash Flow | -0.59 | -14.89 | -0.03 | -0.01 | -0.02 | - |
| Issuance of Common Stock | - | - | - | 28.74 | 1.5 | 15.09 |
| Other Financing Activities | 0.27 | 0 | - | - | -0.11 | -0.32 |
| Financing Cash Flow | 0.27 | 0 | - | 28.74 | 1.39 | 14.77 |
| Foreign Exchange Rate Adjustments | -0.02 | -0.01 | - | - | - | - |
| Net Cash Flow | -6.03 | -26.1 | -7.45 | 21.77 | -4.68 | 12.28 |
| Free Cash Flow | -5.69 | -11.22 | -7.45 | -6.97 | -6.07 | -2.49 |
| Free Cash Flow Per Share | -0.31 | -0.62 | -0.41 | -0.46 | -0.42 | -0.20 |
| Levered Free Cash Flow | -4.45 | -7.58 | -5.56 | -4.72 | -3.82 | - |
| Unlevered Free Cash Flow | -4.45 | -7.58 | -5.56 | -4.71 | -3.82 | - |
| Change in Net Working Capital | -0.86 | 1.01 | -0.64 | 1.65 | 0.76 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.